Regulatory Submissions & FDA Correspondence
510(k) Premarket Notifications
Pre-Submission Meetings
Breakthrough Device Designations
Investigational Device Exemptions
De Novo Reclassification Exemptions
Enforcement Discretion Confirmation
513(g) Requests
Official FDA Correspondent
Regulatory Strategy Development
Software as a Medical Device & Digital Health
Wearables & Remote Monitoring
Next-Generation Medical Imaging & AI
Antimicrobial & Infection Control Claims
Neonatology & Perinatal Health
Women’s Health & Urology
Pulmonary & Respiratory Health
Metabolic & Endocrine Health
Neurology & Mental Health
Rehabilitation & Assistive Devices
Orthopedic & Implantable Devices
Cardiovascular & Imaging
Other Services
Clinical Trial & Biostatistics Support
Protocol Development
Assessment of Post-market Changes
Ongoing Regulatory Support
Fractional Head of Regulatory Affairs
Comments to Proposed Rules
Peer Reviewer